F-18 FDG PET/CT Assessment of Gastrointestinal Stromal Tumor Response to Sunitinib Malate Therapy

2008 ◽  
Vol 33 (3) ◽  
pp. 211-212 ◽  
Author(s):  
Ignacio Banzo ◽  
Remedios Quirce ◽  
Isabel Martinez-Rodriguez ◽  
Julio Jimenez-Bonilla ◽  
Aurora Sainz-Esteban ◽  
...  
Keyword(s):  
Gastrointestinal Stromal Tumor ◽  
Fdg Pet ◽  
Tumor Response ◽  
Stromal Tumor ◽  
Sunitinib Malate ◽  
Pet Ct ◽  
Fdg Pet Ct

Inflammatory Myofibroblastic Tumor Mimicking Gastric Gastrointestinal Stromal Tumor on 18F-FDG PET/CT

2014 ◽  
Vol 39 (8) ◽  
pp. 725-727 ◽  
Author(s):  
Ari Chong ◽  
Jung-Min Ha ◽  
Ran Hong ◽  
Sang-Gon Park ◽  
Hee Jeong Lee
Keyword(s):  
Gastrointestinal Stromal Tumor ◽  
Fdg Pet ◽  
Inflammatory Myofibroblastic Tumor ◽  
Stromal Tumor ◽  
Pet Ct ◽  
18F Fdg ◽  
Fdg Pet Ct

Primary Extragastrointestinal Stromal Tumor on FDG PET/CT

2018 ◽  
Vol 43 (9) ◽  
pp. 702-703 ◽  
Author(s):  
Yanyan Zhang ◽  
Annan Zhang ◽  
Le Song ◽  
Xinxin Li ◽  
Weifang Zhang
Keyword(s):  
Fdg Pet ◽  
Stromal Tumor ◽  
Extragastrointestinal Stromal Tumor ◽  
Pet Ct ◽  
Fdg Pet Ct

Basal 18F-FDG PET/CT as a predictive biomarker of tumor response for neoadjuvant therapy in breast cancer

2016 ◽  
Vol 35 (2) ◽  
pp. 81-87 ◽  
Author(s):  
A.M. García Vicente ◽  
A. Soriano Castrejón ◽  
R.E. Pruneda-González ◽  
G. Fernández Calvo ◽  
M.M. Muñoz Sánchez ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Neoadjuvant Therapy ◽  
Fdg Pet ◽  
Tumor Response ◽  
Predictive Biomarker ◽  
Pet Ct ◽  
18F Fdg ◽  
Fdg Pet Ct

Tumor response to neoadjuvant chemotherapy in patients with esophageal cancer assessed with CT and FDG-PET/CT – RECIST 1.1 vs. PERCIST 1.0

2018 ◽  
Vol 101 ◽  
pp. 65-71 ◽  
Author(s):  
Soichi Odawara ◽  
Kazuhiro Kitajima ◽  
Takayuki Katsuura ◽  
Yasunori Kurahashi ◽  
Hisashi Shinohara ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Neoadjuvant Chemotherapy ◽  
Fdg Pet ◽  
Tumor Response ◽  
Recist 1.1 ◽  
Pet Ct ◽  
Percist 1.0 ◽  
Fdg Pet Ct ◽  
Response To Neoadjuvant Chemotherapy

scholarly journals A prospective trial comparing FDG ‐ PET / CT and CT to assess tumor response to cetuximab in patients with incurable squamous cell carcinoma of the head and neck

2014 ◽  
Vol 3 (6) ◽  
pp. 1493-1501 ◽  
Author(s):  
Douglas Adkins ◽  
Jessica Ley ◽  
Farrokh Dehdashti ◽  
Marilyn J. Siegel ◽  
Tanya M. Wildes ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Fdg Pet ◽  
Tumor Response ◽  
Prospective Trial ◽  
Pet Ct ◽  
Fdg Pet Ct

scholarly journals Usefulness of 18F-FDG PET/CT, LDH and tumor markers in the prognosis and evaluation of tumor response after RMB therapy in advanced, metastatic colorectal cancer (mCRC)

2017 ◽  
Vol 28 ◽  
pp. iii12
Author(s):  
Angelica Nazarian ◽  
Zoe Andrada ◽  
Joanne Thomas ◽  
Sudipta Sureshbabu ◽  
Nathaniel Berman ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Tumor Markers ◽  
Fdg Pet ◽  
Tumor Response ◽  
Pet Ct ◽  
18F Fdg ◽  
Fdg Pet Ct

scholarly journals A2-07: Usefulness of FDG-PET/CT for evaluation of tumor response after stereotactic radiosurgery in primary or metastatic lung cancer

2007 ◽  
Vol 2 (8) ◽  
pp. S315
Author(s):  
Jung Hoon Kim ◽  
Eun Kyung Choi ◽  
Jung Shin Lee ◽  
Jin Sook Ryu ◽  
Woo-Sung Kim ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Stereotactic Radiosurgery ◽  
Fdg Pet ◽  
Tumor Response ◽  
Metastatic Lung Cancer ◽  
Pet Ct ◽  
Metastatic Lung ◽  
Fdg Pet Ct
Sign in / Sign up

Export Citation Format

Share Document